Journal of Nuclear Medicine, volume 61, issue 1, pages 6-12

Prostate-Specific Membrane Antigen–Guided Surgery

Maurer Tobias 1
Graefen Markus 2
van der Poel Henk G. 3
Hamdy Freddie 4
Briganti Alberto 5
Eiber Matthias 6
Wester Hans Jürgen 7, 8
van Leeuwen Fijs W.B. 9, 10
1
 
1Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany
2
 
Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany
3
 
Department of Urology, Antoni van Leeuwenhoek Hospital–The Netherlands Cancer Institute, Amsterdam, The Netherlands
8
 
and.
9
 
Department of Urology, Antoni Van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, The Netherlands
10
 
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Centre, Leiden, The Netherlands.
Publication typeJournal Article
Publication date2019-11-15
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor9.3
ISSN01615505, 2159662X
Radiology, Nuclear Medicine and imaging
Abstract
Since its introduction to the diagnostic pathway for prostate cancer management, prostate-specific membrane antigen (PSMA)-ligand PET has demonstrated great potential. PSMA-ligand imaging is increasingly influencing therapeutic decision making, although its impact on patient outcomes still needs to be defined. One relatively new application, enabled through chemical and engineering efforts, is PSMA-guided surgery. This review highlights the potential of PSMA-guided surgery and discusses its implications in lymph node dissection in primary and recurrent prostate cancer.

Citations by journals

1
2
Journal of Nuclear Medicine
Journal of Nuclear Medicine, 2, 7.41%
Journal of Nuclear Medicine
2 publications, 7.41%
Frontiers in Oncology
Frontiers in Oncology, 2, 7.41%
Frontiers in Oncology
2 publications, 7.41%
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 1, 3.7%
Journal of Medicinal Chemistry
1 publication, 3.7%
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 1, 3.7%
European Journal of Medicinal Chemistry
1 publication, 3.7%
European Journal of Hybrid Imaging
European Journal of Hybrid Imaging, 1, 3.7%
European Journal of Hybrid Imaging
1 publication, 3.7%
EJNMMI Research
EJNMMI Research, 1, 3.7%
EJNMMI Research
1 publication, 3.7%
Clinical Nuclear Medicine
Clinical Nuclear Medicine, 1, 3.7%
Clinical Nuclear Medicine
1 publication, 3.7%
Pharmaceuticals
Pharmaceuticals, 1, 3.7%
Pharmaceuticals
1 publication, 3.7%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 3.7%
International Journal of Molecular Sciences
1 publication, 3.7%
Annals of Nuclear Medicine
Annals of Nuclear Medicine, 1, 3.7%
Annals of Nuclear Medicine
1 publication, 3.7%
World Journal of Urology
World Journal of Urology, 1, 3.7%
World Journal of Urology
1 publication, 3.7%
Colloids and Surfaces B: Biointerfaces
Colloids and Surfaces B: Biointerfaces, 1, 3.7%
Colloids and Surfaces B: Biointerfaces
1 publication, 3.7%
Clinical and Translational Imaging
Clinical and Translational Imaging, 1, 3.7%
Clinical and Translational Imaging
1 publication, 3.7%
Bioconjugate Chemistry
Bioconjugate Chemistry, 1, 3.7%
Bioconjugate Chemistry
1 publication, 3.7%
Tumor Diagnostik und Therapie
Tumor Diagnostik und Therapie, 1, 3.7%
Tumor Diagnostik und Therapie
1 publication, 3.7%
Geburtshilfe und Frauenheilkunde
Geburtshilfe und Frauenheilkunde, 1, 3.7%
Geburtshilfe und Frauenheilkunde
1 publication, 3.7%
JAMA Oncology
JAMA Oncology, 1, 3.7%
JAMA Oncology
1 publication, 3.7%
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics, 1, 3.7%
Molecular Cancer Therapeutics
1 publication, 3.7%
Onkourologiya
Onkourologiya, 1, 3.7%
Onkourologiya
1 publication, 3.7%
Siberian Journal of Oncology
Siberian Journal of Oncology, 1, 3.7%
Siberian Journal of Oncology
1 publication, 3.7%
European Urology Focus
European Urology Focus, 1, 3.7%
European Urology Focus
1 publication, 3.7%
Diagnostics
Diagnostics, 1, 3.7%
Diagnostics
1 publication, 3.7%
Memo - Magazine of European Medical Oncology
Memo - Magazine of European Medical Oncology, 1, 3.7%
Memo - Magazine of European Medical Oncology
1 publication, 3.7%
European Journal of Nuclear Medicine and Molecular Imaging
European Journal of Nuclear Medicine and Molecular Imaging, 1, 3.7%
European Journal of Nuclear Medicine and Molecular Imaging
1 publication, 3.7%
1
2

Citations by publishers

1
2
3
4
5
6
7
Springer Nature
Springer Nature, 7, 25.93%
Springer Nature
7 publications, 25.93%
Elsevier
Elsevier, 3, 11.11%
Elsevier
3 publications, 11.11%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 3, 11.11%
Multidisciplinary Digital Publishing Institute (MDPI)
3 publications, 11.11%
American Chemical Society (ACS)
American Chemical Society (ACS), 2, 7.41%
American Chemical Society (ACS)
2 publications, 7.41%
Society of Nuclear Medicine and Molecular Imaging
Society of Nuclear Medicine and Molecular Imaging, 2, 7.41%
Society of Nuclear Medicine and Molecular Imaging
2 publications, 7.41%
Frontiers Media S.A.
Frontiers Media S.A., 2, 7.41%
Frontiers Media S.A.
2 publications, 7.41%
Thieme
Thieme, 2, 7.41%
Thieme
2 publications, 7.41%
Wolters Kluwer Health
Wolters Kluwer Health, 1, 3.7%
Wolters Kluwer Health
1 publication, 3.7%
American Medical Association (AMA)
American Medical Association (AMA), 1, 3.7%
American Medical Association (AMA)
1 publication, 3.7%
American Association for Cancer Research (AACR)
American Association for Cancer Research (AACR), 1, 3.7%
American Association for Cancer Research (AACR)
1 publication, 3.7%
Publishing House ABV Press
Publishing House ABV Press, 1, 3.7%
Publishing House ABV Press
1 publication, 3.7%
Tomsk National Research Medical Center of the Russian Academy of Sciences
Tomsk National Research Medical Center of the Russian Academy of Sciences, 1, 3.7%
Tomsk National Research Medical Center of the Russian Academy of Sciences
1 publication, 3.7%
1
2
3
4
5
6
7
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Maurer T. et al. Prostate-Specific Membrane Antigen–Guided Surgery // Journal of Nuclear Medicine. 2019. Vol. 61. No. 1. pp. 6-12.
GOST all authors (up to 50) Copy
Maurer T., Graefen M., van der Poel H. G., Hamdy F., Briganti A., Eiber M., Wester H. J., van Leeuwen F. W. Prostate-Specific Membrane Antigen–Guided Surgery // Journal of Nuclear Medicine. 2019. Vol. 61. No. 1. pp. 6-12.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.2967/jnumed.119.232330
UR - https://doi.org/10.2967%2Fjnumed.119.232330
TI - Prostate-Specific Membrane Antigen–Guided Surgery
T2 - Journal of Nuclear Medicine
AU - Maurer, Tobias
AU - Graefen, Markus
AU - van der Poel, Henk G.
AU - Hamdy, Freddie
AU - Briganti, Alberto
AU - Eiber, Matthias
AU - Wester, Hans Jürgen
AU - van Leeuwen, Fijs W.B.
PY - 2019
DA - 2019/11/15 00:00:00
PB - Society of Nuclear Medicine and Molecular Imaging
SP - 6-12
IS - 1
VL - 61
SN - 0161-5505
SN - 2159-662X
ER -
BibTex |
Cite this
BibTex Copy
@article{2019_Maurer,
author = {Tobias Maurer and Markus Graefen and Henk G. van der Poel and Freddie Hamdy and Alberto Briganti and Matthias Eiber and Hans Jürgen Wester and Fijs W.B. van Leeuwen},
title = {Prostate-Specific Membrane Antigen–Guided Surgery},
journal = {Journal of Nuclear Medicine},
year = {2019},
volume = {61},
publisher = {Society of Nuclear Medicine and Molecular Imaging},
month = {nov},
url = {https://doi.org/10.2967%2Fjnumed.119.232330},
number = {1},
pages = {6--12},
doi = {10.2967/jnumed.119.232330}
}
MLA
Cite this
MLA Copy
Maurer, Tobias, et al. “Prostate-Specific Membrane Antigen–Guided Surgery.” Journal of Nuclear Medicine, vol. 61, no. 1, Nov. 2019, pp. 6-12. https://doi.org/10.2967%2Fjnumed.119.232330.
Found error?